A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

Men diagnosed with prostate cancer have traditionally faced two choices: do nothing and hope the tumor doesn’t grow between ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer ...

Up to 85 percent of prostate cancers are diagnosed in the early stages, when they are still curable.Even when diagnosed at an advanced stage, most prostate cancers respond well to treatment. The first ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Oncologists and urologists identified several barriers to treatment intensification for metastatic castration-sensitive ...

Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...

Prostate and skin cancers are among the most common cancers affecting men. In Advanced Prostate Cancer, lifelong treatment ...

Approximately half of men with metastatic castration-resistant prostate cancer and BRCA1 or BRCA2 mutations do not receive medications that could improve their survival.Poly (adenosine ...